In comparison to the flood of emergency use authorizations doled out by the FDA throughout the COVID-19 pandemic, the number of those tests and devices that have gone on to receive full, non-pandemic ...
Latest technology offers a compact, portable and easy-to-use system for dialysis providers Includes two-way connectivity to securely transfer prescription and treatment data Can be used alongside ...
DEERFIELD - Baxter International Inc. said U.S. Food and Drug Administration has approved its next-generation Artificial Kidney 98 dialysis machine, which is designed to be a portable and easy-to-use ...
Baxter has received an FDA clearance for its latest, portable dialysis machine designed to connect directly with electronic medical records for patients’ prescriptions and treatment data. The ...
Baxter International Inc. BAX recently received U.S. FDA clearance of its next-generation Artificial Kidney 98 (AK 98) dialysis machine, which can be used simultaneously with the company’s novel ...
(RTTNews) - Baxter International Inc. (BAX) said Friday that it has received U.S. FDA 510(k) Clearance for its next-generation Artificial Kidney 98 dialysis machine. It is designed to be a portable ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx ...
CHICAGO (AP) -- A lawsuit filed against Baxter International Inc. on Tuesday asks for damages on behalf of patients who used its ``potentially deadly'' dialysis machines, which are blamed in dozens of ...
DEERFIELD, Ill. (AP) — Drug and medical device maker Baxter International plans to buy the privately held Swedish company Gambro AB for about $2.76 billion to broaden its dialysis product portfolio.
Please provide your email address to receive an email when new articles are posted on . Baxter International plans to spin off its renal care and acute therapies global business units into an ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of its next-generation ...